Global Blood Components, Testing and Collection Market Spurred by Sudden Increases in New Infections

Premier Source of Biotech, Medical & Life Science Market Research Reports

With consumers insisting on zero-risk blood supply, large investments are being put into development of pathogen reduction solutions.

Viral inactivation technologies for blood constituents will stimulate the next phase of development in the blood banking systems and plasma products market.”
— Anasuya Vemuri

HYDERABAD, TELANGANA, INDIA, January 27, 2016 /EINPresswire.com/ -- RI Technologies' market research report on Blood – Components, Testing & Collection gives an insight into different areas including Blood Products, Blood Banking Devices (Such as Equipment involved in Collecting, Processing and Storing Blood and Blood Components), Blood Testing and Other (Such as Artificial Blood, Cord Blood and Recombinant Factors). Blood Products include Cellular Blood Components, Whole Blood and Plasma Derived Products (Immunoglobulins, Coagulation factors, Alpha-1 proteinase inhibitors, Albumins, Fibrin and Anti-Coagulants). Blood Testing includes Immunoassays, NAT and Other. The report provides an in depth analysis of each of the type and product areas by their respective categories. The study includes estimates and projections (2005 - 2020) for the total global Blood Research and Products market and also key regional markets that include North America, Europe, Japan, Asia-Pacific and Rest of World.

This study is an ideal research tool providing strategic business intelligence to the corporate sector. This report may help strategists, investors, laboratories, pharmaceutical companies, contract research organizations, biotechnology companies and drug approval authorities in --
* Gauging Competitive Intelligence
* Identifying Key Growth Areas and Opportunities
* Understanding Geographic Relevance to Product
* Knowing Regional Market Sizes and Growth Opportunities and Restraints
* Keeping Tab on Emerging Technologies
* Tapping New Markets

Demand for blood products is set to rise in developed as well as developing countries due to aging population that needs sophisticated testings and intricate operations as well as rapid advancement and ready availability of advanced technologies. Hemoglobin-based oxygen carriers (HBOCs) and PFC-based products also may provide significant growth to the market. Even though people are now alert to the different infections, the industry is yet to overcome difficulties such as security, and the accessibility to good quality blood. This has led to very strict safety measurements being taken for both the donors as well as the blood banks which have to be adhered to before any transfusion is carried out. The risk of diseases spread through transfusions has decreased due to conduction of thorough testing and screening techniques and also with the assistance from latest technologies. Current conversion rates from plasma-derived to recombinant factor products are increasing the standard factor product cost. Collecting blood manually continues to be the most productive technique for collecting blood and the systems that are used in these procedures are extremely important to the blood banking industry.

Blood banks now readily await a safe technology that will combine with their processing systems and decrease the danger of transfusion-related infections to almost nil. The success of the market is ascertained by the capacity to provide cost-effective technologies with a wide kill range, strong safety profile and the effortlessness in the application. The provision to persuade the buyer decision making processes combined with first-mover advantage will be significant in achieving a competitive edge. The market will observe a strong operation towards combining device production knowledge and biopharmaceutical technology, as companies work towards producing safer blood collection techniques and blood replacements.

To order this market research report on Blood – Components, Testing & Collection, please contact us at contactus@researchimpact.com. You may also explore custom research services on Blood – Components, Testing & Collection with RI Technologies.


About RI Technologies

Research Impact Technologies, www.researchimpact.com, is a premier market research provider. The company believes in pure research that will trigger action for immediate customer needs rather than plain reporting of data. The reports provide strategic information tools that help to probe into and support critical business decisions. RI Technologies believes in broadening the value of market research obtained through several dedicated streams of information. Investment banks, companies, management consultants, trade associations, corporate executives, business analysts, libraries, universities, and business schools stand to benefit from RI Technologies' unique market research reports.

Anasuya Vemuri
Research Impact Technologies
+91 9676994272
email us here